QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Upgrades

 10-biggest-price-target-changes-for-tuesday

Goldman Sachs raised the price target for Zoom Video Communications Inc (NASDAQ: ZM) from $187 to $402. Zoom Video shares r...

 bmo-capital-downgrades-akcea-therapeutics-to-market-perform-lowers-price-target-to-1815

BMO Capital analyst Do Kim downgrades Akcea Therapeutics (NASDAQ:AKCA) from Outperform to Market Perform and lowers the pric...

 60-biggest-movers-from-yesterday
60 Biggest Movers From Yesterday
09/01/2020 09:07:39

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to...

Core News & Articles

Toward the end of trading Monday, the Dow traded down 0.72% to 28446.24 while the NASDAQ rose 1% to 11,812.92. The S&P also...

Core News & Articles

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the compa...

Core News & Articles

Midway through trading Monday, the Dow traded down 0.94% to 28385.03 while the NASDAQ rose 0.23% to 11722.14. The S&P also ...

 akcea-therapeutics-rallies-after-majority-owner-ionis-agrees-to-buy-remaining-stake

Akcea Therapeutics Inc (NASDAQ: AKCA) shares were rallying strongly Monday following a buyout deal.

Core News & Articles

Following the market opening Monday, the Dow traded down 0.60% to 28483.09 while the NASDAQ rose 0.26% to 11,725.76. The S&...

 looking-into-akcea-therapeuticss-return-on-capital-employed

During Q2, Akcea Therapeutics's (NASDAQ: AKCA) reported sales totaled $22.38 million. Despite a 12.89% in earnings, the com...

 38-stocks-moving-in-mondays-pre-market-session

Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed t...

 the-week-ahead-in-biotech-aug-24-29-lipocine-binary-event-liver-congress-in-the-spotlight

After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21.

 akcea-announces-new-pricing-and-reimbursement-of-waylivra-in-germany

BOSTON, Aug. 13, 2020 /PRNewswire/ -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceutica...

 akcea-therapeutics-q2-eps-049-misses-035-estimate-sales-2238m-miss-3093m-estimate

Akcea Therapeutics (NASDAQ:AKCA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of ...

 the-daily-biotech-pulse-voyager-abbvie-end-collaboration-thumbs-down-for-dbvs-peanut-allergy-patch-tiziana-expedites-covid-19-trial-plans

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3)

 earnings-scheduled-for-august-4-2020

Companies Reporting Before The Bell • AdaptHealth Inc. (NASDAQ:AHCO) is estimated to report quarterly earnings at $0.19 per sh...

 the-week-ahead-in-biotech-novavax-coronavirus-vaccine-readout-fda-decisions-and-more-earnings

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION